Association between nonalcoholic liver disease and chronic kidney disease: An ultrasound analysis from NHANES 1988-1994

American Journal of Nephrology

Volumn 36, Issue 5, 2012, Pages 466-471

  Sirota, Jeffrey C ^a   McFann, Kim ^a   Targher, Giovanni ^b   Chonchol, Michel ^a   Jalal, Diana I ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c Mail Stop C 281 ^*  (United States)

Author keywords

Chronic kidney disease; NHANES; Nonalcoholic fatty liver disease

Indexed keywords

TRIACYLGLYCEROL;

ADULT; AGE; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIORITY JOURNAL; RACE; SEX; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX;

EID: 84868250561     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000343885     Document Type: Article

References (25)

1. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S: Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos Nutrition and Liver Study. Hepatology 2005; 42:44-52.
2. Jimba S, Nakagami T, Takahashi M, Waka-matsu T, Hirota Y, Iwamoto Y, Wasada T: Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 2005; 22: 1141-1145.
3. Marchesini G, Bugianesi E, Forlani G, Cer-relli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-923.
4. Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G: Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30:1212-1218.
5. Mirbagheri SA, Rashidi A, Abdi S, Saedi D, Abouzari M: Liver: an alarm for the heart? Liver Int 2007; 27:891-894.
6. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D: Predic tors of new-onset kidney disease in a community-based population. JAMA 2004; 291:844-850.
7. Johns BR, Pao AC, Kim SH: Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals. Nephrol Dial Transplant 2012; 27:1410-1415.
8. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD: Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2011; 6:2364-2373.
9. Dogru T, Genc H, Tapan S, Aslan F, Ercin CN, Ors F, Kara M, Sertoglu E, Karslioglu Y, Bag-ci S, Kurt I, Sonmez A: Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease. Clin Endo-crinol (Oxf) 2012, E-pub ahead of print.
10. Stefan N, Kantartzis K, Haring HU: Causes and metabolic consequences of fatty liver. Endocr Rev 2008; 29:939-960.
11. Chang Y, Ryu S, Sung E, Woo HY, Oh E, Cha K, Jung E, Kim WS: Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism 2008; 57: 569-576.
12. Targher G, Bertolini L, Rodella S, Lippi G, Zoppini G, Chonchol M: Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol 2010; 5:2166-2171.
13. Targher G, Bertolini L, Rodella S, Zoppini G, Lippi G, Day C, Muggeo M: Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treat-ed retinopathy in type 2 diabetic patients. Diabetologia 2008; 51: 444-450.
14. Targher G, Chonchol M, Bertolini L, Rodella S, Zenari L, Lippi G, Franchini M, Zoppini G, Muggeo M: Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol 2008; 19: 1564-1570.
15. Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, Kato T, Takeda N, Oku-da J, Ida K, Kawahito Y, Yoshikawa T, Okan-oue T: The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007; 102: 2708-2715.
16. Targher G, Marra F, Marchesini G: Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epi-phenomenon? Diabetologia 2008; 51: 1947-1953.
17. Edmison J, McCullough AJ: Pathogenesis of non-alcoholic steatohepatitis: human data. Clin Liver Dis 2007; 11:75-104, ix.
18. Albano E, Mottaran E, Occhino G, Reale E, Vidali M: Review article: role of oxidative stress in the progression of non-alcoholic steatosis. Aliment Pharmacol Ther 2005; 22(suppl 2):71-73.
19. Neuschwander-Tetri BA, Caldwell SH: Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003; 37: 1202-1219.
20. de Alwis NM, Day CP: Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008; 48(suppl 1):S104-S112.
21. Targher G, Chonchol M, Zoppini G, Abate-russo C, Bonora E: Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? J Hepatol 2011; 54:1020-1029.
22. Carrero JJ, Park SH, Axelsson J, Lindholm B, Stenvinkel P: Cytokines, atherogenesis, and hypercatabolism in chronic kidney disease: a dreadful triad. Semin Dial 2009; 22:381-386.
23. Ix JH, Sharma K: Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol 2010; 21:406-412.
24. Targher G, Bertolini L, Chonchol M, Rodella S, Zoppini G, Lippi G, Zenari L, Bonora E: Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinop-athy in type 1 diabetic patients. Diabetologia 2010; 53: 1341-1348.
25. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F: Noninvasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resona nce. J Hepatol 2009; 51: 433-445.